Biofilm formation in Acinetobacter baumannii: associated features and clinical implications

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
J Rodríguez-BañoSpanish Group for the Study of Nosocomial Infections (GEIH)

Abstract

Biofilm formation in 92 unrelated strains of Acinetobacter baumannii isolated in a multicentre cohort study was investigated using a microtitre plate assay. Fifty-six (63%) isolates formed biofilm. These isolates were less frequently resistant to imipenem or ciprofloxacin than were non-biofilm-forming isolates (25% vs. 47%, p 0.04; and 66% vs. 94%, p 0.004, respectively). All catheter-related urinary or bloodstream infections and the sole case of shunt-related meningitis were caused by biofilm-forming strains. Multivariate analysis revealed that treatment in an intensive care unit, ciprofloxacin resistance and isolation from a respiratory sample were associated with non-biofilm-forming isolates, while previous aminoglycoside use was associated with biofilm-forming isolates.

References

Jun 1, 1988·American Journal of Infection Control·J S GarnerJ M Hughes
Jul 21, 2001·Lancet·P S Stewart, J W Costerton
Nov 3, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jesús Rodríguez-BañoUNKNOWN Grupo de Estudio de Infección Hospitalaria (GEIH)
Oct 12, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J M CisnerosUNKNOWN Spanish Group for Nosocomial Infection (GEIH) for the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIM
Jun 30, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Hervé Richet, Pierre Edouard Fournier

❮ Previous
Next ❯

Citations

May 4, 2011·The Journal of Microbiology·Christin N McQueary, Luis A Actis
Jul 1, 2009·Antimicrobial Agents and Chemotherapy·Tianhong DaiMichael R Hamblin
May 11, 2011·Antimicrobial Agents and Chemotherapy·K MargetisA Skoutelis
May 8, 2013·Infection and Immunity·Bart A EijkelkampMelissa H Brown
Oct 5, 2010·Journal of Bacteriology·María A MussiLuis A Actis
Jan 13, 2011·BMC Research Notes·Sara MartíEmmanuelle Dé
Feb 18, 2011·Critical Care : the Official Journal of the Critical Care Forum·Mònica MagretUNKNOWN EU-VAP/CAP Study Group
Mar 31, 2009·Future Microbiology·Jennifer A Gaddy, Luis A Actis
Oct 12, 2010·Journal of Global Infectious Diseases·Vikas ManchandaNp Singh
Mar 14, 2014·BMC Microbiology·Yassine Nait ChabaneEmmanuelle Dé
Feb 28, 2014·Future Microbiology·Gianfranco Donelli, Claudia Vuotto
Apr 8, 2014·The Journal of Antimicrobial Chemotherapy·Anna FàbregaJordi Vila
Mar 26, 2016·Comparative Immunology, Microbiology and Infectious Diseases·Andreia DuarteFernanda C Domingues
Feb 8, 2014·Current Eye Research·Deepa TalrejaAshok Kumar
Mar 5, 2013·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Ming-Li LiouKai-Chih Chang
Oct 7, 2011·The Journal of Hospital Infection·P EspinalJ Vila
Jan 6, 2010·International Journal of Antimicrobial Agents·Nicola C Gordon, David W Wareham
Mar 28, 2009·The Lancet Infectious Diseases·Baek-Nam KimDavid L Paterson
Mar 3, 2009·Proteomics·María Fernández-ReyesLuis Rivas
Oct 13, 2011·IUBMB Life·Gustavo M Cerqueira, Anton Y Peleg
May 8, 2015·Journal of Medical Microbiology·Indranil Biswas
Aug 28, 2015·Journal of Research in Pharmacy Practice·Mandana Izadpanah, Hossein Khalili
Jul 25, 2015·Genome Announcements·Laura Álvarez-FragaMargarita Poza
Feb 26, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Hyun Ah KimWon-Ki Baek
Nov 7, 2009·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Antonio CascioAntonio David
Mar 15, 2011·Archives of Oral Biology·Carina Maciel da Silva-BoghossianAna Paula Vieira Colombo
Apr 18, 2015·Bioorganic & Medicinal Chemistry Letters·Karthik SambanthamoorthyEric J Wagar
Feb 18, 2009·FEMS Immunology and Medical Microbiology·Lauren B KingLarry S McDaniel
Nov 17, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Y SmaniJ Pachón
Jun 3, 2016·Frontiers in Public Health·Saranya VijayakumarIndranil Biswas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.